Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Cel-Sci reports preclinical data on LEAPS COV-19 peptides

Dec. 3, 2020

U.K. approval for Pfizer and BioNTech's COVID-19 mRNA vaccine BNT-162b2

Dec. 2, 2020

FDA clears IND for phase I study of DHOHD inhibitor RP-7214 for COVID-19

Dec. 2, 2020

DMC completes positive safety review of CYNKCOVID study

Dec. 2, 2020

Investigator-initiated trial to study Carragelose nasal spray for COVID-19 prophylaxis

Dec. 2, 2020

Edesa initiates phase II/III study of EB-05 for hospitalized patients with COVID-19

Dec. 2, 2020

RS-5614 studied in investigator-initiated trial for severe COVID-19

Dec. 2, 2020

New COMMUNITY adaptive platform trial for COVID-19 begins enrollment

Dec. 1, 2020

DMX-200 selected for inclusion in CLARITY 2.0 study for COVID-19

Dec. 1, 2020

Antiviral novaferon exhibits anti-SARS-CoV-2 effects both at cellular level and in COVID-19 patients

Dec. 1, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026